169 related articles for article (PubMed ID: 18766161)
1. D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects.
Hons J; Zirko R; Ulrychova M; Cermakova E; Libiger J
Neuro Endocrinol Lett; 2008 Aug; 29(4):485-92. PubMed ID: 18766161
[TBL] [Abstract][Full Text] [Related]
2. Glycine serum level in schizophrenia: relation to negative symptoms.
Hons J; Zirko R; Ulrychova M; Cermakova E; Doubek P; Libiger J
Psychiatry Res; 2010 Apr; 176(2-3):103-8. PubMed ID: 20096465
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577
[TBL] [Abstract][Full Text] [Related]
5. Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
Hons J; Vasatova M; Cermakova E; Doubek P; Libiger J
J Psychiatr Res; 2012 Jun; 46(6):811-8. PubMed ID: 22502820
[TBL] [Abstract][Full Text] [Related]
6. Testosterone in first-episode schizophrenia.
Cesková E; Prikryl R; Kaspárek T
Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
[TBL] [Abstract][Full Text] [Related]
7. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
Sirota P; Meiman M; Herschko R; Bessler H
Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
[TBL] [Abstract][Full Text] [Related]
8. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
9. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia.
Ko YH; Jung SW; Joe SH; Lee CH; Jung HG; Jung IK; Kim SH; Lee MS
Psychoneuroendocrinology; 2007 May; 32(4):385-91. PubMed ID: 17395394
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
[TBL] [Abstract][Full Text] [Related]
11. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
[TBL] [Abstract][Full Text] [Related]
12. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
Favrod J; Ernst F; Giuliani F; Bonsack C
Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
[TBL] [Abstract][Full Text] [Related]
13. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile.
Pazvantoglu O; Selek S; Okay IT; Sengul C; Karabekiroglu K; Dilbaz N; Erel O
Psychiatry Clin Neurosci; 2009 Oct; 63(5):693-700. PubMed ID: 19788631
[TBL] [Abstract][Full Text] [Related]
14. Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study.
Nakano Y; Yoshimura R; Nakano H; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Ueda N; Nakamura J
Hum Psychopharmacol; 2010 Mar; 25(2):139-44. PubMed ID: 20196178
[TBL] [Abstract][Full Text] [Related]
15. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
Zhang ZJ; Reynolds GP; Ramchand C; Peet M; Shah S
Acta Pharmacol Sin; 2001 Jan; 22(1):76-80. PubMed ID: 11730567
[TBL] [Abstract][Full Text] [Related]
16. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
[TBL] [Abstract][Full Text] [Related]
17. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
[TBL] [Abstract][Full Text] [Related]
18. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.
Petronijević ND; Radonjić NV; Ivković MD; Marinković D; Piperski VD; Duricić BM; Paunović VR
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1921-6. PubMed ID: 18824063
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of CCL11/eotaxin in schizophrenia.
Teixeira AL; Reis HJ; Nicolato R; Brito-Melo G; Correa H; Teixeira MM; Romano-Silva MA
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):710-4. PubMed ID: 18096286
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma leptin in antipsychotic-naïve females with schizophrenia, but not in males.
Wang HC; Yang YK; Chen PS; Lee IH; Yeh TL; Lu RB
Neuropsychobiology; 2007; 56(4):213-5. PubMed ID: 18382119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
